The British government has recommended against pregnant and breastfeeding women receiving the Pfizer COVID-19 vaccine, admitting that “sufficient reassurance of safe use of the vaccine” for the demographic “cannot be provided at the present time.”
The findings were revealed in a comprehensive report from the country’s Department of Health and Social Care, “Summary of the Public Assessment Report for COVID-19 Vaccine Pfizer/BioNTech,” last updated on August 16th. The report was published through the government’s Medicines & Healthcare products Regulatory Agency.
The report’s “Toxicity Conclusions” section outlines why the department recommends against pregnant and breastfeeding women receiving the vaccine, noting:
“In the context of supply under Regulation 174, it is considered that sufficient reassurance of safe use of the vaccine in pregnant women cannot be provided at the present time: however, use in women of childbearing potential could be supported provided healthcare professionals are advised to rule out known or suspected pregnancy prior to vaccination. Women who are breastfeeding should also not be vaccinated.“
“The absence of reproductive toxicity data is a reflection of the speed of development to first identify and select COVID-19 mRNA Vaccine BNT162b2 for clinical testing and its rapid development to meet the ongoing urgent health need. In principle, a decision on Licensing a vaccine could be taken in these circumstances without data from reproductive toxicity studies animals, but there are studies ongoing and these will be provided when available,” continued the report.
The admission follows controversy over several Western governments’ hasty approvals and, in some cases, mandates of COVID-19 vaccines.
In the U.S., following a massive lobbying campaign by pharmaceutical giants including Pfizer, many jobs, businesses, and schools required COVID-19 vaccination for entry. As a result, companies including Pfizer have enjoyed record-breaking profits throughout the COVID-19 pandemic.
The British government’s report also follows U.S. health agencies such as the Food and Drug Administration (FDA) appearing to slow roll the release of data relevant to the efficacy and long-term health implications of the COVID-19 vaccine.